Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10415 (
Bcl-2
)
33,771
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously identified
WRAP53
as an antisense transcript that regulates the p53 tumor suppressor. The
WRAP53
gene also encodes a protein essential for Cajal body formation and involved in cellular trafficking of the survival of motor neuron complex, the telomerase enzyme and small Cajal body-specific RNAs to Cajal bodies. Here, we show that the WRAP53 protein is overexpressed in a variety of cancer cell lines of different origin and that
WRAP53
overexpression promotes cellular transformation. Knockdown of the WRAP53 protein triggers massive apoptosis through the mitochondrial pathway, as demonstrated by Bax/Bak activation, loss of mitochondrial membrane potential and cytochrome c release. The apoptosis induced by
WRAP53
knockdown could moreover be blocked by
Bcl-2
overexpression. Interestingly, human tumor cells are more sensitive to
WRAP53
depletion as compared with normal human cells indicating that cancer cells in particular depends on
WRAP53
expression for their survival. In agreement with this, we found that high levels of
WRAP53
correlate with poor prognosis of head and neck cancer. Together these observations propose a role of
WRAP53
in carcinogenesis and identify
WRAP53
as a novel molecular target for a large fraction of malignancies.
...
PMID:WRAP53 promotes cancer cell survival and is a potential target for cancer therapy. 2136 86